Fig. 2From: Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritisNumber of patients by treatment duration. The number of patients exposed to ixekizumab over a period of 3 years. Total N = 1118; total exposure = 1822.2 patient-yearsBack to article page